Skip to main content
Equibles
GRCE logo

GRCE · Grace Therapeutics, Inc. · Webcasts, Transcripts & Audio

Track GRCE — free

Use GRCE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GRCE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.08 +0.04 (+1.96%) At close · Oct 9
Rebalance outlook locked
Market Cap
$43.75M
Shares
21.04M
Volume · Oct 9 37.79K Avg daily vol (3M) 167.65K

Grace Therapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Grace Therapeutics, Inc. (GRCE), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Annual General Meeting
Investor event
2026-09-17
Grace Therapeutics, Inc. (GRCE) September 2026 Annual General Meeting Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-16
Grace Therapeutics, Inc. (GRCE) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY23 · Q3
2023-02-14
Grace Therapeutics, Inc. (GRCE) Q3 2023 Earnings Call
Diluted EPS
$-0.52
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-11-14
Grace Therapeutics, Inc. (GRCE) Q2 2023 Earnings Call
Diluted EPS
$-0.66
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-08-11
Grace Therapeutics, Inc. (GRCE) Q1 2023 Earnings Call
Diluted EPS
$-0.61
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-06-21
Grace Therapeutics, Inc. (GRCE) Q4 2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-02-14
Grace Therapeutics, Inc. (GRCE) Q3 2022 Earnings Call
Revenue
$
▼ 100% YoY
Diluted EPS
$-0.54
Rev · 2q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2021-11-10
Grace Therapeutics, Inc. (GRCE) Q2 2022 Earnings Call
Diluted EPS
$-0.18
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-08-12
Grace Therapeutics, Inc. (GRCE) Q1 2022 Earnings Call
Diluted EPS
$-0.72
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-06-22
Grace Therapeutics, Inc. (GRCE) Q4 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q1
2020-08-13
Grace Therapeutics, Inc. (GRCE) Q1 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-06-29
Grace Therapeutics, Inc. (GRCE) Q4 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–12 of 12 webcasts
Key facts CIK 1444192 CUSIP 00439U104 Visit website Investor relations